Tyler Goddard assists the firm in pharmaceutical patent prosecution. His area of focus is biochemistry. 

Tyler obtained his PhD in chemical biology from Yale University. During this time, Tyler was a graduate researcher, where he discovered and characterized the biosynthesis and bioactivities of novel bacterial natural products with anti-inflammatory and antibiotic activities. He also discovered enzymes with potential therapeutic applications in the treatment of aging-associated diseases.

As an undergraduate at Baylor University, Tyler received his BS in biochemistry. As an undergraduate researcher, he worked in a medicinal chemistry lab focused on the synthesis of anti-cancer compounds. He was a recipient of the Virgil Tweedie Scholarship in Chemistry and Biochemistry, awarded to top undergraduates in chemistry.

Tyler is listed as a co-inventor on two patents.

  • NIH Chemistry-Biology Interface Predoctoral Training Fellow
  • Virgil Tweedie Scholarship in Chemistry and Biochemistry


  • Park, H.B.*, Goddard, T.N.*, Oh, J., Patel, J., Wei, Z., Perez, C.E., Mercado, B.Q., Wang, R., Wyche, T., Piizzi,G., Flavell, R.A., Crawford, J.M. Bacterial autoimmune drug metabolism transforms an immunomodulator intostructurally and functionally divergent antibiotics. Angew Chem Int Ed. * denotes co-first authorship
  • Kim, N.Y., Goddard, T.N., Sohn, S., Spiegel, D.A., Crawford, J.M. Biocatalytic reversal of advanced glycation end product modification. ChemBioChem. 2019, 20, 2402-2410





Expand All

Tyler Goddard assists the firm in pharmaceutical patent prosecution. His area of focus is biochemistry. 

Tyler obtained his PhD in chemical biology from Yale University. During this time, Tyler was a graduate researcher, where he discovered and characterized the biosynthesis and bioactivities of novel bacterial natural products with anti-inflammatory and antibiotic activities. He also discovered enzymes with potential therapeutic applications in the treatment of aging-associated diseases.

As an undergraduate at Baylor University, Tyler received his BS in biochemistry. As an undergraduate researcher, he worked in a medicinal chemistry lab focused on the synthesis of anti-cancer compounds. He was a recipient of the Virgil Tweedie Scholarship in Chemistry and Biochemistry, awarded to top undergraduates in chemistry.

Tyler is listed as a co-inventor on two patents.

  • NIH Chemistry-Biology Interface Predoctoral Training Fellow
  • Virgil Tweedie Scholarship in Chemistry and Biochemistry
  • Park, H.B.*, Goddard, T.N.*, Oh, J., Patel, J., Wei, Z., Perez, C.E., Mercado, B.Q., Wang, R., Wyche, T., Piizzi,G., Flavell, R.A., Crawford, J.M. Bacterial autoimmune drug metabolism transforms an immunomodulator intostructurally and functionally divergent antibiotics. Angew Chem Int Ed. * denotes co-first authorship
  • Kim, N.Y., Goddard, T.N., Sohn, S., Spiegel, D.A., Crawford, J.M. Biocatalytic reversal of advanced glycation end product modification. ChemBioChem. 2019, 20, 2402-2410